| |
| |
|
| Insider
Information: |
Blair James C |
| Relationship: |
10% Owner |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
24 |
|
| Direct
Shares |
127,185 |
|
|
Indirect Shares
|
2,985,991 |
|
|
| Direct
Value |
$138,020 |
|
|
|
Indirect Value
|
$9,984,028 |
|
|
| Total
Shares |
3,113,176 |
|
|
| Total
Value |
$10,122,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Welltek Incorporated |
WTKND |
Director |
2008-03-07 |
0 |
2008-03-07 |
0 |
Premium* |
|
|
Nuvasive Inc |
NUVA |
Director |
2007-05-09 |
3,457 |
2007-05-09 |
0 |
Premium* |
|
|
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-10 |
37,586 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
67,875 |
Premium* |
|
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
70,916 |
2008-07-16 |
62,513 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
Director, 10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
19,373 |
2011-12-22 |
50,643 |
Premium* |
|
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
Director, 10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
Director |
2019-08-16 |
33,439 |
2019-08-20 |
30,105 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
183 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WTKND |
Welltek Incorporated |
Director |
– • – |
2006-05-04 |
4 |
B |
$19.98 |
$5,698,296 |
I/I |
285,200 |
10,600 |
2.1 |
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2006-12-06 |
4 |
S |
$23.90 |
$213,120 |
I/I |
(8,919) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
– – • |
2006-12-12 |
4 |
S |
$25.62 |
$330,498 |
I/I |
(12,900) |
21,068 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2019-03-14 |
4 |
S |
$27.79 |
$473,986 |
I/I |
(17,056) |
0 |
0 |
- |
|
| WTKND |
Welltek Incorporated |
Director |
– • – |
2004-06-01 |
4 |
S |
$38.66 |
$417,025 |
I/I |
(10,787) |
19,360 |
|
- |
|
| WTKND |
Welltek Incorporated |
Director |
– • – |
2004-11-10 |
4 |
S |
$50.19 |
$512,189 |
I/I |
(10,205) |
9,155 |
|
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2015-03-05 |
4 |
S |
$77.70 |
$662,626 |
I/I |
(8,528) |
35,506 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2017-08-04 |
4 |
S |
$78.61 |
$1,450,355 |
I/I |
(18,450) |
17,056 |
0 |
- |
|
183 Records found
|
|
Page 8 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
